StockData
Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc. (PLSE) stock

PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$44.84−1.52 (-3.28%)

Close on Nov 17, 2026Market cap $3.20BP/E –Yield –

Pulse Biosciences r&d expenses

Research and development expenses are spending on new products and technology.

Pulse Biosciences's R&D Expenses for the twelve months ending Jun 30, 2026 was $51.89M, up 27.3% year over year. For fiscal 2025 it was $44.72M, up 38.3% from the year before. Over ten years it grew 35.3% a year on average. The highest annual figure on record is $44.72M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$44.72M+38.3%
FY2024Dec 31, 2024$32.34M+16.3%
FY2023Dec 31, 2023$27.80M+33.4%
FY2022Dec 31, 2022$20.84M-27.2%
FY2021Dec 31, 2021$28.64M+8.3%
FY2020Dec 31, 2020$26.44M+5.9%
FY2019Dec 31, 2019$24.96M+44.7%
FY2018Dec 31, 2018$17.25M+78.9%
FY2017Dec 31, 2017$9.65M+75.2%
FY2016Dec 31, 2016$5.51M+152.5%
FY2015Dec 31, 2015$2.18M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$16.98M+40.4%
Q1 FY2026Mar 31, 2026$12.59M+22.1%
Q4 FY2025Dec 31, 2025$10.93M+2.5%
Q3 FY2025Sep 30, 2025$11.39M+47.9%
Q2 FY2025Jun 30, 2025$12.09M+67.2%
Q1 FY2025Mar 31, 2025$10.31M+53.0%
Q4 FY2024Dec 31, 2024$10.66M+36.7%
Q3 FY2024Sep 30, 2024$7.70M+3.1%
Q2 FY2024Jun 30, 2024$7.23M+8.0%
Q1 FY2024Mar 31, 2024$6.74M+15.6%
Q4 FY2023Dec 31, 2023$7.80M+90.5%
Q3 FY2023Sep 30, 2023$7.47M+65.4%
Q2 FY2023Jun 30, 2023$6.70M+22.7%
Q1 FY2023Mar 31, 2023$5.83M-13.9%
Q4 FY2022Dec 31, 2022$4.10M-27.6%
Q3 FY2022Sep 30, 2022$4.52M-30.1%
Q2 FY2022Jun 30, 2022$5.46M-26.8%
Q1 FY2022Mar 31, 2022$6.77M-25.3%
Q4 FY2021Dec 31, 2021$5.66M-23.8%
Q3 FY2021Sep 30, 2021$6.46M-7.3%
Q2 FY2021Jun 30, 2021$7.46M+27.1%
Q1 FY2021Mar 31, 2021$9.06M+46.6%
Q4 FY2020Dec 31, 2020$7.43M+12.7%
Q3 FY2020Sep 30, 2020$6.97M+12.5%
Q2 FY2020Jun 30, 2020$5.87M-7.4%
Q1 FY2020Mar 31, 2020$6.18M+5.8%
Q4 FY2019Dec 31, 2019$6.59M+29.7%
Q3 FY2019Sep 30, 2019$6.19M+22.9%
Q2 FY2019Jun 30, 2019$6.34M+60.0%
Q1 FY2019Mar 31, 2019$5.84M+84.0%
Q4 FY2018Dec 31, 2018$5.08M+77.4%
Q3 FY2018Sep 30, 2018$5.04M+72.2%
Q2 FY2018Jun 30, 2018$3.96M+85.9%
Q1 FY2018Mar 31, 2018$3.18M+83.8%
Q4 FY2017Dec 31, 2017$2.86M+73.7%
Q3 FY2017Sep 30, 2017$2.93M+88.3%
Q2 FY2017Jun 30, 2017$2.13M–
Q1 FY2017Mar 31, 2017$1.73M–
Q4 FY2016Dec 31, 2016$1.65M–
Q3 FY2016Sep 30, 2016$1.55M–

More Pulse Biosciences figures

See a number that looks wrong?